The importance of translational research in brain injury.
Progress in the understanding of the pathophysiologic process and management of brain injury provides a unique challenge to the young investigator. Currently, there are teams both in the laboratory and clinical settings which may or may not interact as a result of the depth and breadth of the problems before them. For example, laboratory teams may be focused on cellular or molecular mechanisms of injury while the clinical investigator is attempting to deal with refractory ICP and it's treatment. It is clear that many aspects of biological research must indeed be approached using molecular techniques of neuroscience and much has been learned. However, the translational aspect of this effort may be elusive as it is unclear at present how these molecular techniques translate into the intensive care unit and the patient. For many, the research paths taken in the laboratory and ICU will always remain independent. For those who desire a more direct pathway to treatment, the "bench to bedside" approach is one which is more likely to yield results. Several examples will be given to strengthen the notion that we must not abandon the translational aspect of research but to embrace the process if we are to further improve outcome from brain injury.
Marmarou
A
A
Division of Neurosurgery, Medical College of Virginia Commonwealth University, Richmond, Virginia, USA. amarmaro@vcu.edu
D000818:Animals; D035843:Biomedical Research; D001930:Brain Injuries / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D002986:Clinical Trials as Topic; D003422:Critical Care; D006801:Humans; D019586:Intracranial Hypertension / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D007427:Intracranial Pressure; D012106:Research; D018581:Technology Transfer